The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: A 5-year overview

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 3, 2007, Pages 604-606

  Toh, Cheng H ^a   Hoots, W K ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; FIBRINOGEN; UNCLASSIFIED DRUG;

APACHE; ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RATING SCALE; SYSTEMATIC REVIEW; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOSIS; BLOOD; BLOOD EXAMINATION; HOSPITALIZATION; METABOLISM; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD;

DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMATOLOGIC TESTS; HUMANS; PLATELET COUNT; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTHROMBIN TIME; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34247594942     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02313.x     Document Type: Article

References (15)

1. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation on behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 86: 1327-30.
2. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 1995; 74: 848-52.
3. Wada H, Gabazza EC, Asakura H, Koike K, Okamoto K, Maruyama I, Shiku H, Nobori T. Comparison of diagnostic criteria for disseminated intravascular coagulation: Diagnostic criteria of the International Society of Thrombosis and Haemostasis and of the Japanese Ministry of Health and Welfare for Overt DIC. Am J Hematol 2003; 74: 17-22.
4. Matsumoto T, Wada H, Nishioka Y, Nishio M, Abe Y, Nishioka J, Kamikura Y, Sase T, Kaneko T, Houdijk WP, Nobori T, Shiku H. Frequency of abnormal biphasic aPTT clot waveforms in patients with underlying disorders associated with disseminated intravascular coagulation. Clin Appl Thromb Hemost 2006; 12: 185-92.
5. Gando S, Wada H, Asakura H, Iba T, Eguchi Y, Okamoto K, Ohtomo Y, Kawasugi K, Koga S, Koseki K, Tsuji H, Mayumi T, Murata A, Nakagawa M, Endo S. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 2005; 11: 71-6.
6. Bakhtiari K, Meijers J, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 43: 2416-21.
7. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients; comparing current criteria. Crit Care Med 2006; 34: 625-31.
8. Cauchie P, Cauchie C, Boudjelta KZ, Carlier E, Deschepper N, Govaerts D, Migaud-Fressart M, Woodhams B, Brohee D. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital-meaning of the ISTH score system, fibrin monomers and lipoprotein-C-reactive protein complex formation. Am J Hematol 2006; 91: 414-9.
9. Angstwurm MW, Dempfle CE, Spannagl M. New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 2006; 34: 314-20.
10. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004; 2: 1924-33.
11. Kienast J, Juers M, Wiedermann CJ, Hoffman JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept Investigators. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006; 4: 90-7.
12. Dempfle CE, Wurst M, Smolinski M, Lorenz S, Osika A, Olenik D, Fiedler F, Borggrefe M. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 2004; 91: 812-8.
13. Toh CH, Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2005; 16: 69-74.
14. Kinasewitz GT, Zein JG, Lee GL, Nazir SA, Taylor FB Jr. Prognostic value of a simple evolving DIC score in patients with severe sepsis. Crit Care Med 2005; 33: 2214-21.
15. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005; 33: 341-8.